MeSH tree: D04.711
The latest findings from the PROTECT phase III trial show sparsentan—a novel treatment for IgA nephropathy—significantly reduces proteinuria, or abnormal protein levels in the urine, compared to standard treatment irbesartan.
Apr 3, 2023
0
95
With increased use of screening CT for early detection of lung cancer, many more cases of suspicious lung nodules are being identified. However, differentiation of benign from malignant lung nodules remains a challenge that ...
Jan 17, 2023
0
34
The nascent field of fluorescence-guided surgery (FGS) is fast growing, with the potential to vastly improve the safety and efficacy of surgical procedures. In FGS, tissues of interest are targeted and labeled using special ...
Jan 6, 2023
0
47
A team of researchers from the George Washington University School of Engineering and Applied Science has spent the past two years developing electrospun nanofiber fabrics for masks and air filters designed to sift out and ...
Jul 28, 2022
0
39
